Introduction {#S1}
============

The kidney is a vital organ that performs a number of essential functions including blood filtration and clearance of endogenous waste products. Podocytes are specialized epithelial cells that contribute critically to the kidney's "filtration apparatus". Podocyte dysfunction and/or damage has been associated with both acute and chronic glomerular diseases including focal segmental glomerulosclerosis, diabetic nephropathy and HIV nephropathy ([@R1], [@R2], [@R3], [@R4]--[@R6]). Podocyte depletion leads to glomerulosclerosis in murine models and recent studies suggest that short-lived localized insults can trigger a cascade of secondary damage that causes more global injury ([@R7]--[@R9]). Understanding how podocytes respond to injury and whether they are capable of regeneration will provide valuable information for the development of new therapies that seek to replace damaged or lost podocytes ([@R10]).

The Zebrafish is a widely used vertebrate model organism for the study of developmental mechanisms and disease pathologies for many organs. It combines many advantages including genetic tractability of both forward and reverse genetics, accessibility to observation and manipulation during organogenesis, and a great capability for regeneration after injury([@R11]--[@R18]). Studies from multiple groups have established zebrafish as a useful model system to study kidney development and function([@R19]--[@R22]). Despite the structural simplicity of the zebrafish pronephros, consisting of a single glomerulus in connection with two pronephric tubules, it possesses a glomerular filtration apparatus with a similar complexity to that of the mammalian kidney([@R21], [@R23]). More recently, it has been utilized as an alternative *in vivo* model for studying kidney injury and regeneration ([@R16], [@R24]--[@R26]).

The zebrafish kidney has a remarkable ability to regenerate after injury, and kidney stem/progenitor cells have been identified in adults([@R16], [@R26]). Similar to a recent report ([@R27]), we have independently established two transgenic zebrafish lines where green fluorescence protein (GFP) and a fusion protein of GFP and the bacterial nitroreductase (NTR) are expressed in podocytes under the control of the *podocin* promoter. In the Tg*(podocin:GFP)* line, the podocytes are fluorescently tagged allowing them to be visualized, isolated, and tracked *in vivo* whereas the Tg*(podocin:NTR-GFP)* line utilizes bacterial NTR to convert the nontoxic pro-drug metronidazole (Mtz) into a cytotoxic, DNA cross-linking agent that induces cell death([@R28], [@R29]). Here, we report that specific podocyte ablation and glomerular dysfunction occurs in Tg*(podocin:NTR-GFP)* embryos after treatment with Mtz. Interestingly, following Mtz washout there is a recovery of glomerular filtration barrier function that is associated with podocyte proliferation in the glomerulus and a restoration of normal podocyte foot-process architecture. These findings suggest that zebrafish podocytes are capable of regeneration following depletion and establish the Tg*(podocin:NTR-GFP)* line as a useful model to identify new therapeutic targets involved in the response of podocytes to injury.

Results and Discussion {#S2}
======================

Expression of *GFP* and *GFP-NTR* under the control of podocyte specific *podocin* promoter {#S3}
-------------------------------------------------------------------------------------------

We isolated a 3.5-kb DNA fragment located upstream of the *podocin* gene that has previously been found to contain the mouse *podocin* promoter ([@R30], [@R31]). We subsequently ligated GFP and GFP-NTR under the control of this promoter in the Tol2 transposon vector and injected zebrafish embryos with these constructs ([@R32])([Fig. 1A](#F1){ref-type="fig"}). By out-crossing with wild type fish, we identified 4 independent founders for both transgenic fish lines, Tg*(podocin:GFP)* and Tg*(podocin:NTR-GFP)* respectively. Embryos from each of the founders displayed identical expression patterns in which GFP was expressed exclusively in the region of the pronephric glomerulus from 60 hours post-fertilization (hpf) by fluorescence microscopy ([Fig. 1B](#F1){ref-type="fig"}). The founders with the strongest GFP expression were used to collect embryos for study and line maintenance. Consistent with these lines expressing GFP in podocytes, we found that the GFP signal localized to the site of *nephrin* expression ([Fig. 1C](#F1){ref-type="fig"}), and they both colocalized with the site of NTR expression in Tg*(podocin:NTR-GFP)* laval fish ([Fig. 1D](#F1){ref-type="fig"}).

Conditional ablation of podocytes results in a loss of podocyte marker expression and the slit diaphragm, and defective glomerular barrier function {#S4}
---------------------------------------------------------------------------------------------------------------------------------------------------

We next determined the conditions under which Mtz will induce conditional ablation of podocytes. Wild type, Tg*(podocin:GFP)* and Tg*(podocin:NTR-GFP)* larval fish at 70 hpf were incubated with Mtz for 12--48 hours at concentrations ranging from 1--20 mM. Exposure to Mtz for 12 hours resulted in pericardial edema in Tg*(podocin:NTR-GFP*) larval fish, consistent with renal failure ([Fig. 2A](#F2){ref-type="fig"}). The extent of pericardia edema was more pronounced with increasing Mtz concentration or prolonged exposure even when low (2 mM) concentration of Mtz was used (data not shown). Concomitant with the presence of pericardial edema, the intensity of the GFP signal in the glomerulus of Mtz treated Tg*(podocin:NTR-GFP*) larval fish was significantly reduced in a dose dependent fashion ([Fig 2B](#F2){ref-type="fig"}). A robust effect was found when Tg*(podocin:NTR-GFP*) embryos were exposed to Mtz at 4 or 10 mM for 12 hours with \~95% (n=41/43) of the animals showing a dramatic reduction or loss of GFP fluorescence in the glomerulus ([Fig. 2B and 2C, b](#F2){ref-type="fig"}). No effects on GFP signal or the appearance of pericardial edema was observed in Mtz treated Tg*(podocin:GFP*) embryos for 12 or 48 hr ([Fig. 2A](#F2){ref-type="fig"} left panel, and 2C, a). When Mtz concentrations \>20 mM were used we observed non-specific toxicity, characterized by necrosis of the larva without significant pericardial edema in all groups (Tg*(podocin:NTR-GFP*), Tg*(podocin:GFP*) and wild type fish; data not shown). Whole mount *in situ* hybridization showed that the loss of GFP fluorescence induced by Mtz was concomitant with loss of the expression of *nephrin* ([Fig. 2C, d](#F2){ref-type="fig"} and [Fig. 4A, j and k](#F4){ref-type="fig"}) and *podocin* in the glomerulus ([Fig. 4A, f and g](#F4){ref-type="fig"}). Despite significant edema and reduced expression of GFP/*nephrin*/*podocin* induced by Mtz in Tg*(podocin:NTR-GFP)* animals, we did not detected any abnormalities or change of gene expression in Mtz treated Tg*(podocin:GFP)* and wild type larval fish, or in Tg*(podocin:NTR-GFP*) larval fish without Mtz treatment. Ultrastructural examination of the glomerulus from Mtz treated Tg*(podocin:NTR-GFP*) larval fish by electron microscopy (EM) revealed the presence of podocyte foot process effacement ([Fig. 3A, b](#F3){ref-type="fig"}). A more severe disruption in foot process architecture and areas of podocyte denudation was detected in animals following exposure to Mtz for 72 hours ([Fig. 3A, d](#F3){ref-type="fig"}). Consistent with this, quantitation of the podocytopathy by classifying the areas of injury into mild, moderate, severe, and denuded ([Fig. 3B](#F3){ref-type="fig"}), according to established methods ([@R25]), confirmed that 72 hrs of Mtz treatment caused greater injury than 12 hrs of Mtz treatment ([Fig. 3C](#F3){ref-type="fig"}). Interestingly, despite severe damage of podocytes in some of the Mtz treated fish, the morphology of the glomerular basement membrane and the endothelium remained well preserved ([Fig. 3A, d](#F3){ref-type="fig"}), indicating that the NTR mediated cell damage is confined to podocytes.

NTR is known to induce cell death by converting Mtz into a DNA cross-linking agent ([@R33]). In line with this, chromatin condensation, a hallmark of the onset of apoptosis, was clearly detected by EM in some of the podocytes in Mtz treated Tg*(Podocin:NTR-GFP)* larval fish ([Fig. 3A, c](#F3){ref-type="fig"}). We further investigated Mtz induced podocyte apoptosis using the TUNEL assay ([Fig. 2C, e and f](#F2){ref-type="fig"}). While no apoptotic cells were detected in the glomeruli of Mtz treated wild type (data not shown) and Tg*(Podocin:GFP)* ([Fig. 2C, e](#F2){ref-type="fig"}) controls (n=30 respectively), we observed strong apoptotic signals in the glomeruli of Mtz-treated Tg*(Podocin:NTR-GFP)* animals (n=30) ([Fig. 2C, f](#F2){ref-type="fig"}). These apoptotic cells co-stained with the anti-panCrb antibody, which recognizes the Crumbs protein Crb2b on podocytes ([@R34]), confirming that the dying cells were podocytes ([Fig. 2C, f](#F2){ref-type="fig"}). Taken together, these results indicate that apoptosis of podocytes is responsible for the loss of GFP fluorescence and *nephrin/podocin* expression in the glomeruli of Mtz-treated Tg*(Podocin:NTR-GFP)* animals. However, we cannot rule-out that NTR-induced injury downregulates *podocin* and *nephrin* expression independently of podocyte cell death or that podocyte cell death causes secondary damage to surrounding cells such as the endothelium, pronephric tubules, and mesangial cells. Interplays between podocyte, endothelial cells and mesangial cell has been suggested to be critical for the survival and/or development of the complex architecture and function of the glomerulus ([@R35]--[@R38]).

Albuminuria is considered to be a hallmark of glomerulopathy and has been widely used as an important clinical marker for diagnosis, monitoring disease progression and remission in patients with chronic kidney diseases ([@R39], [@R40]). To functionally assess the effects of podocyte depletion on the glomerular filtration barrier of Mtz-treated Tg*(Podocin:NTR-GFP)* animals, we injected rhodamine-conjugated albumin into the circulation of larval fish. If the glomerular filtration barrier is compromised, the albumin tracer will pass into the pronephros and be taken up by proximal tubule cells. 5--6 hours after injection, rhodamine-albumin containing vesicles were detected inside the cells of the pronephric tubules in Mtz treated Tg*(Podocin:NTR-GFP)* larval fish ([Fig. 4B](#F4){ref-type="fig"}, middle), but not in Tg*(Podocin:NTR-GFP)* larval fish without Mtz treatment ([Fig. 4B](#F4){ref-type="fig"}, left panel) or in Mtz treated Tg*(Podocin:GFP)* fish (data not shown).

Structural and functional recovery of podocytes after NTR/Mtz induced podocyte ablation {#S5}
---------------------------------------------------------------------------------------

Although still controversial in mammals, recent studies have shown that the zebrafish kidney contains renal stem/progenitor cells and regenerates after acute kidney injury([@R16], [@R26]). To investigate the regenerative capacity of podocytes after NTR/Mtz-mediated ablation, we performed Mtz washout experiments. After treatment with 4 mM Mtz for 12 hours, Mtz was washed away and the fish were observed periodically under light and fluorescence microscope to assess their pericardial edema and glomerular GFP fluorescence. Four days post Mtz washout, weak but visible GFP signal re-appeared in the glomeruli of Tg*(podocin:NTR-GFP)* animals. By 7 days post Mtz washout, the glomerular GFP fluorescence had become more intense and both *nephrin* and *podocin* transcripts could be re-detected ([Fig. 4A, d, h, l](#F4){ref-type="fig"}). In addition, the pericardial edema had resolved (data not shown).

To determine whether the re-appearance of GFP fluorescence and expression of *podocin* and *nephrin* also results in a corresponding recovery in the structure of the previously ablated glomerulus, we examined podocyte ultrastructure by EM. A re-establishment of slit diaphragms was found in Mtz-treated Tg*(podocin:NTR-GFP)* animals starting at 4 days post Mtz washout although the majority of podocytes displayed a 'moderate' degree of effacement at this stage ([Fig. 3A, e, and 3C](#F3){ref-type="fig"}). At 7 days post Mtz washout, well-formed foot processes linked by slit diaphragms were found with the majority of podocytes showing only a 'mild' degree of effacement ([Fig. 3A, f and 3C](#F3){ref-type="fig"}). A recovery in the glomerular barrier function was examined by the rhodamine conjugated-bovine albumin filtration. In Tg*(podocin:NTR-GFP)* animals 7 days post Mtz washout, no rhodamine-albumin-positive vesicles were detected in the proximal tubules ([Fig. 4B](#F4){ref-type="fig"}, right panel) consistent with a functional recovery of the NTR/Mtz damaged glomerulus.

To understand whether podocyte proliferation contributes to the recovery of the NTR/Mtz-damaged glomerulus, cell proliferation was examined by 5-bromo-2-deoxyuridine (BrdU) labeling. BrdU was injected into circulation and two to four hours later, larval fish were fixed and BrdU incorporation detected by immunofluorescence staining using anti-BrdU antibody. A low level of BrdU incorporation was seen in glomeruli from Tg*(podocin:NTR-GFP)* larval fish without Mtz treatment ([Fig. 4C](#F4){ref-type="fig"}, left panel). Despite the presence of BrdU labeling in neighboring cells of the glomerulus and pronephric tubules, almost no BrdU incorporation was detected in the glomeruli in Tg*(Podocin:NTR-GFP)* larval fish treated with Mtz for 12 hours. The GFP fluorescence signal was also significantly reduced in the glomerulus of these animals ([Fig. 4C](#F4){ref-type="fig"}, middle panel). However, greatly increased BrdU labeling was observed in Tg*(podocin:NTR-GFP)* animals 7 days post Mtz washout. The majority of these BrdU labeled cells also expressed GFP, consistent with being podocytes and implicating podocyte proliferation in the glomerular recovery from NTR-induced injury.

In summary, we have shown here the utility of the Mtz/NTR system to cause glomerular damage by using the *podocin* promoter to specifically restrict the apoptotic-inducing effects of NTR to podocytes. This system is temporally inducible, highly efficient, and the duration of the ablation can be exquisitely controlled by washout experiments. Using this genetic tool, we demonstrated that podocyte depletion leads to effacement and a loss of slit diaphragms and glomerular barrier function. Remarkably, about a week following Mtz washout, the glomerulus is able to recover functionality, restoring foot process architecture and filtration integrity. This regeneration is associated with podocyte proliferation, suggesting that zebrafish podocytes can re-enter the cell cycle and replenish cells lost to injury. Alternatively, new podocytes may be derived from a resident stem/progenitor cell population, such as the putative CD133+CD24+CD106+ stem cells identified in the Bowman's capsule of human glomeruli ([@R41]). By combining this tool with forward genetic or chemical screens it should now be possible to identify new genes and novel compounds that accelerate podocyte recovery from injury

CONCISE METHODS {#S6}
===============

Zebrafish culture {#S7}
-----------------

Wild type and transgenic zebrafish (*Danio rerio*) embryos, larvae and adult fish were raised and maintained under standard laboratory conditions([@R42]).

Chemicals, reagents and antibodies {#S8}
----------------------------------

Rhodamine B isothiocyanate conjugated bovine albumin, FITC-dextran 10 kDa, 5-bromo-2-deoxyuridine (BrdU), Metronidazole (Mtz) were purchased from Sigma-Aldrich (St. Louis MO). The terminal deoxynucleotidyl transferase--mediated deoxyuridinetriphosphate nick end-labeling (TUNEL)-In Situ Cell Death Detection Kit, TMR red was from Roche (catalog no. 12156792910). Mouse anti --BrdU antibody was purchased from Invitrogen. The rabbit anti-panCrb antibody was a kind gift from Dr. J. Malicki ([@R34], [@R43]). Fluorescence conjugated secondary antibodies were obtained from Jackson laboratory.

Generation of Podocin driven *GFP* and *GFP-Nitroreductase* constructs and zebrafish lines {#S9}
------------------------------------------------------------------------------------------

A 3540 bp DNA fragment from zebrafish genomic DNA corresponding to the 5′ end of the zebrafish *podocin* gene was cloned by PCR amplification using primers (forward) 5′-TACGCTTGAGCAACTAAATGAATGGC-3; (reverse) 5′-GTGAAGTGTCCTCTGGTGTTTGG-3′. The PCR fragment was subsequently cloned into a pGEM-T Easy vector (*pGEM-PodP)*. To generate the constructs for Tg*(podocin:NTR-GFP*) and Tg*(podocin:GFP)* transgenic fish, we use the *pTol2-Slc2a15b-NTR/GFP* and *pTol2-Slc2a15b-GFP* constructs (Dr. Davidson, NZ) as templates to replace the *Slc2a15b* promoter with *podocin* promoter fragment. After obtaining *pTol2-podocin:GFP* and *pTol2-podocin:NTR-GFP* constructs, they were co-injected with *Tol2* transposase RNA([@R32]) into two-cells stage zebrafish embryos for genomic integration and generating stable transgenic lines. Adult carriers of Tg*(podocin:GFP)* and Tg*(podocin:NTR-GFP)* were identified by screening their progeny for GFP fluorescence. Adult fish expressing transgene were out-crossed to wild type fish to obtain the germ-line transgenics.

NTR/Metronidazole mediated podocyte ablation {#S10}
--------------------------------------------

Zebrafish embryos were collected from timed pair mating of F1 Tg*(podocin:GFP)*, Tg*(podocin:GFP-NTR)* and wild-type fish about 60--70 hpf (with visible GFP fluorescence in the glomerulus) and dechorionated. Mtz was freshly prepared in 0.1% ETOH and added to fish water. The larval fish were treated with various concentrations of Mtz for 12, 24, 48 and 72 hours in the dark. For recovery experiment, the Mtz-containing medium was replaced with 3--4 changes of fresh embryo medium, and embryos/ larvae were returned to 28°C, and monitored every 6--12 hours. Minimal 15 embryos/larvae were in each group under each treatment condition. Each experiment was repeated for at least three times. The control experiment was set up as following: wild-type +ETOH (control 1); Tg*(Podocin:NTR-GFP)* + ETOH (control 2); wild-type +Mtz (control 3) and Tg*(podocin:GFP)* +Mtz (control 4) and Tg*(podocin:NTR-GFP)* +Mtz (experiment). The morphology of the fish and the intensity of the fluorescence signal in the glomerulus were monitored by stereomicroscope and fluorescence microscope respectively.

Whole mount in situ hybridization {#S11}
---------------------------------

Whole mount in situ hybridization was performed as previously reported ([@R44]) with the modification of longer proteinase K treatment of 30 minutes for 4 dpf embryos and 1 hour of treatment for fish at or beyond 7 dpf.

Transmission electron microscopy {#S12}
--------------------------------

Zebrafish larvae were first fixed in 4% paraformaldehyde/PBS at 4°C overnight, then transferred to 2.0% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.4 (Electron Microscopy Sciences, Hatfield, PA) overnight at 4°C, then rinsed in cacodylate buffer and post-fixed in 1.0% osmium tetroxide in cacodylate buffer for one hour at room temperature, followed by dehydration through a graded series of ethanol to 100%. They were then infiltrated with Epon resin (Ted Pella, Redding, CA) in a 1:1 solution of Epon: 100% ethanol overnight on a rotator. The following day, they were embedded in fresh Epon at 60°C overnight. Thin sections were cut on a Leica EM UC7 ultramicrotome, collected onto formvar-coated grids and stained with uranyl acetate and lead citrate. All grids were examined in a JEOL JEM 1011 transmission electron microscope at 80 kV. Images were collected using an AMT digital imaging system (Advanced Microscopy Techniques, Danvers, MA).

TUNEL cell death assay {#S13}
----------------------

The terminal deoxynucleotidyl transferase--mediated deoxyuridinetriphosphate nick end-labeling (TUNEL) assay was performed using the In Situ Cell Death Detection Kit, TMR red (Roche catalog no. 12156792910) and follow manufacturer's instruction with modification. After staining, fish embryos were embedded in 2% agarose block, dehydrated and embedded in JB-4 resin (Polysciences). After polymerization, the resin block was cut into 5 μM-thick section, mounted and viewed under fluorescence microscopy.

Glomerular filtration assay {#S14}
---------------------------

Zebrafish larvae aged 3.5--4 dpf were anaesthetized with Tricaine prior to injections. Rhodamine B isothiocyanate conjugated bovine albumin (Sigma) was diluted in PBS to make a final concentration of 1 mg/ml. FITC-dextran 10 kDa was diluted to 10mg/ml in PBS. Approximately 23 nl of rhodamine-albumin or FITC-dextran solution was injected into retro-orbital vasculature in each animal. Six hours after injection, animals were harvested and fixed in 4% paraformaldehyde/PBS, and processed for embedding in JB-4 resin as mentioned previously. Finally the block was sectioned and viewed directly under fluorescence microscopy. In addition to rhodamine conjugated-albumin, FITC-dextran of 10 kDa (10 mg/ml, 23 nl total) was also injected into each animal as an internal control. In some of the recovery experiments, 10 kDa FITC-dextran was avoided because of the interference of FITC dextran signal with the re-appearance of GFP signal in recovered podocytes. 10 kDa FITC dextran is freely filtered by the glomerulus into the tubules system and be uptake by tubular cells. However, the rhodamine labeled albumin will not be filtered under normal circumstance by the glomerulus and therefore will not appear in the tubular system/tubular cells unless there is a leakiness/destruction of the glomerular filtration barrier. This assay has frequently been used as a readout of the permeability/barrier function of the glomerulus in animals ([@R45]).

Cell proliferation assay- BrdU incorporation {#S15}
--------------------------------------------

5-bromo-2-deoxyuridine (BrdU) (Sigma) was diluted in PBS to make a final concentration of 100 uM. Approximate 23 nl of the BrdU solution was injected into each animal. Two hours after BrdU injection, animals were harvested and fixed in 4% paraformaldehyde/PBS and processed for JB4 embedding. After section, tissues slices were stained with anti-BrdU antibody following manufacturer's instruction (Invitrogen).
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![GFP and NTR-GFP expression under the 3.5-kb *podocin* promoter\
**A.** Constructs used to generate the *podocin* driven GFP (left panel) and NTR-GFP (right panel) transgenic lines are shown respectively. **B.** GFP expression in glomeruli from transgenic fish Tg*(podocin:GFP)*(left panel, arrow) and Tg*(podocin:NTR-GFP)*(right panel, arrow). **C.** GFP expression (panels in B) overlaps with *nephrin* expression in glomeruli from Tg*(podocin:GFP)* (left panel, arrow) and Tg*(podocin:NTR-GFP)* (right panel, arrow) embryos. **D.** NTR is expressed in glomeruli from Tg*(podocin:NTR-GFP)*(right panel, arrows), but absent in glomeruli from Tg*(podocin:GFP)* embryos (left panel).](nihms436350f1){#F1}

![Metronidazole induces podocyte specific ablation\
**A.** Mtz induced pericardial edema is seen in Tg*(podocin:NTR-GFP)* fish (right panel, indicated by the arrowhead) but not in Tg*(podocin:GFP)* fish (left panel). **B.** Treatment with Mtz results in attenuation and eventually loss of the GFP signal in the glomerulus of Tg*(podocin:NTR-GFP)* animals in a dose dependent manner (live images of glomeruli are shown in the upper panels and quantitation of fluorescence is shown in the lower graph). \* indicates *p*\<0.05, \*\* indicates *p*\<0.01. **C.** A loss of GFP fluorescence and *nephrin* transcripts is seen in the glomeruli of Tg*(podocin:NTR-GFP)* fish (b and d respectively), but not in Tg*(podocin:GFP)*(a and c respectively) after treatment with Mtz for 12 hours. Arrows indicate the glomerulus. TUNEL-positive apoptotic cells (red) that co-label with the anti-panCrb antibody (green) are detected in the glomerulus of Mtz treated Tg*(podocin:NTR-GFP)* animals (f, arrows), but not in Mtz treated Tg*(podocin:GFP)* fish (e). N, notochord. \* indicates the glomerulus.](nihms436350f2){#F2}

![Ultrastructural examination of podocytes in Mtz treated Tg*(podocin:GFP)* and Tg*(podocin:NTR-GFP)* fish larvae\
**A.** Electron microscopy examination of Mtz treated Tg*(podocin:GFP)* larval fish shows normal podocyte morphology, intact foot processes and normal appearing glomerular basement membrane (a). Examination of Tg*(podocin:NTR-GFP)* fish treated for 12 hours with Mtz reveals the presence of foot process enfacement (b and c, indicated by arrows). Chromatin condensation and early nuclear fragmentation in podocytes is clearly seen at 12 hours post exposure to Mtz indicating podocyte apoptosis (c). A complete loss of foot process and significant podocyte destruction are observed in fish treated with Mtz for 72 hours (d), however, the morphology of neighboring endothelial cells appear grossly normal with intact intercellular junctional structures and glomerular basement membrane (b and d, arrowheads indicate intercellular junctional structures). 4 days after Mtz washout, foot process-like structures appear attached to the glomerular basement membrane in the glomerulus (arrows in e). 7 days after washout, near complete recovery of foot processes and slit diaphragms are found in the glomerulus (f). **B.** The change in podocyte ultrastructure in response to Mtz treatment and subsequent recovery after Mtz washout is categorized into mild, moderate, severe and denuded injuries based on established methods ([@R25]). **C.** Quantitation of damage of podocytes after Mtz treatment and podocyte recovery 4 day and 7 days after Mtz washout. Podo, podocyte. Endo, endothelial cell. BS, Bowman's space. Cap, capillary space.](nihms436350f3){#F3}

![Dynamic changes in gene expression, glomerular function, and cell proliferation during Mtz induced podocyte injury and recovery after Mtz washout\
**A.** GFP fluorescence is reduced and then absent after Mtz treatment for 12 and 48 hours, respectively (b--c), but reappears at 7 days after Mtz wash out (d). Arrows indicate the glomerulus. Whole mount *in situ* hybridization for *podocin* (f--h) and *nephrin* (j--l) transcripts reveals the concomitant loss and re-appearance of expression corresponding with the change in GFP fluorescence in the glomerulus of Mtz-treated Tg*(podocin:NTR-GFP)* animals. No change in GFP expression (a), or *podocin* (e) and *nephrin* (i) expression is seen in the glomerulus of Tg*(podocin:NTR-GFP)* animals without Mtz treatment. **B.** Assessment of glomerular filtration function using the rhodamine-conjugated albumin filtration assay. 5--6 hours after retro-orbital injection of rhodamine-albumin, rhodamine-albumin containing vesicles are detected inside pronephric tubule cells of Mtz treated Tg*(Podocin:NTR-GFP)* fish (middle panel, inset shows a higher magnified view of the tubule with arrowheads indicating red rhodamine-albumin containing vesicles inside the proximal tubular cells). Rhodamine-positive vesicles are not seen in untreated Tg*(Podocin:NTR-GFP)* control fish, although the uptake of freely filtered 10 kDa FITC-dextran is detected in these animals (left panel, arrowhead in inset indicates green FITC-dextran containing vesicles). No rhodamine-positive vesicles are seen in the pronephric tubule cells in recovered Tg*(Podocin:NTR-GFP)* animals at 7 days post Mtz washout (right panel). **C.** Detection of proliferating cells by BrdU incorporation. A small number of BrdU-positive cells are seen in the glomerulus of untreated Tg*(podocin:NTR-GFP)* laval fish (left panel, arrow indicates the red-colored BrdU signal in the nucleus. Green fluorescence marks NTR-GFP expressing podocytes). In Tg*(Podocin:NTR-GFP)* fish larvae treated with Mtz for 12 hours, despite the presence of BrdU labeling in neighboring cells of the glomerulus and pronephric tubules (arrows), almost no BrdU incorporation is detected in the glomerulus and the GFP fluorescence of podocytes is significant reduced (middle panel). Greatly increased BrdU staining is detected in the glomerulus of Tg*(podocin:NTR-GFP)* fish at 7 days post Mtz washout (right panel) (arrows). Overall GFP fluorescence is also increased in the glomerulus of these recovered animals. Some of the BrdU labeled cells are apparently also expressing GFP. N, notochord. Pt, pronephric tubule. \* indicates glomerulus\*.](nihms436350f4){#F4}
